Early research (Phase 1)Study completedNCT00734890
What this trial is testing
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma
Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+2 more
National Institutes of Health Clinical Center (CC) 18